116 related articles for article (PubMed ID: 2766309)
1. Positive anticalcitonin immunoscintigraphy in patients with medullary thyroid carcinoma.
Manil L; Boudet F; Motte P; Gardet P; Saccavini JC; Lumbroso JD; Schlumberger M; Caillou B; Bazin JP; Ricard M
Cancer Res; 1989 Oct; 49(19):5480-5. PubMed ID: 2766309
[TBL] [Abstract][Full Text] [Related]
2. Immunoscintigraphy in medullary thyroid cancer using an 123I- or 111In-labelled monoclonal anti-CEA antibody fragment.
Reiners C; Eilles C; Spiegel W; Becker W; Börner W
Nuklearmedizin; 1986 Dec; 25(6):227-31. PubMed ID: 3808964
[TBL] [Abstract][Full Text] [Related]
3. Medullary-thyroid-carcinoma imaging in an animal model: use of radiolabeled anticalcitonin F(ab')2 and meta-iodobenzylguanidine.
Guilloteau D; Baulieu JL; Besnard JC
Eur J Nucl Med; 1985; 11(6-7):198-200. PubMed ID: 4076227
[TBL] [Abstract][Full Text] [Related]
4. Contribution of different scintigraphic techniques to the management of medullary thyroid carcinoma.
Sandrock D; Blossey HC; Steinroeder M; Munz DL
Henry Ford Hosp Med J; 1989; 37(3-4):173-4. PubMed ID: 2576957
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
Barbet J; Peltier P; Bardet S; Vuillez JP; Bachelot I; Denet S; Olivier P; Leccia F; Corcuff B; Huglo D; Proye C; Rouvier E; Meyer P; Chatal JF
J Nucl Med; 1998 Jul; 39(7):1172-8. PubMed ID: 9669389
[TBL] [Abstract][Full Text] [Related]
6. Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.
Vuillez JP; Peltier P; Caravel JP; Chetanneau A; Saccavini JC; Chatal JF
J Clin Endocrinol Metab; 1992 Jan; 74(1):157-63. PubMed ID: 1727816
[TBL] [Abstract][Full Text] [Related]
7. Imaging of medullary carcinoma of the thyroid using 111In-labelled anti-CEA monoclonal antibody fragments.
O'Byrne KJ; Hamilton D; Robinson I; Sweeney E; Freyne PJ; Cullen MJ
Nucl Med Commun; 1992 Mar; 13(3):142-8. PubMed ID: 1557212
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoimaging of metastatic medullary carcinoma of the thyroid gland using an indium-111-labeled monoclonal antibody to CEA.
Edington HD; Watson CG; Levine G; Tauxe WN; Yousem SA; Unger M; Kowal CD
Surgery; 1988 Dec; 104(6):1004-10. PubMed ID: 3194829
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoscintigraphy using iodine-131-anti-CEA monoclonal antibodies and thallium-201 scintigraphy in medullary thyroid carcinoma: a case report.
Zanin DE; van Dongen A; Hoefnagel CA; Bruning PF
J Nucl Med; 1990 Nov; 31(11):1854-5. PubMed ID: 2231001
[TBL] [Abstract][Full Text] [Related]
10. Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments.
Buraggi GL; Callegaro L; Mariani G; Turrin A; Cascinelli N; Attili A; Bombardieri E; Terno G; Plassio G; Dovis M
Cancer Res; 1985 Jul; 45(7):3378-87. PubMed ID: 4005860
[TBL] [Abstract][Full Text] [Related]
11. Localization of residual medullary thyroid cancer by thallium/technetium scintigraphy.
Talpos GB; Jackson CE; Froelich JW; Kambouris AA; Block MA; Tashjian AH
Surgery; 1985 Dec; 98(6):1189-96. PubMed ID: 2866591
[TBL] [Abstract][Full Text] [Related]
12. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP
J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753
[TBL] [Abstract][Full Text] [Related]
13. [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
Eising EG; Farahati J; Bier D; Knust EJ; Reiners C
Nuklearmedizin; 1995 Feb; 34(1):1-7. PubMed ID: 7724358
[TBL] [Abstract][Full Text] [Related]
14. Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma.
Hoefnagel CA; Delprat CC; Marcuse HR; de Vijlder JJ
J Nucl Med; 1986 Dec; 27(12):1854-7. PubMed ID: 3097277
[TBL] [Abstract][Full Text] [Related]
15. Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125.
Lehtovirta P; Kairemo KJ; Liewendahl K; Seppälä M
Cancer Res; 1990 Feb; 50(3 Suppl):937s-940s. PubMed ID: 2297745
[TBL] [Abstract][Full Text] [Related]
16. Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylnitrile scintigraphy: a case report.
O'Driscoll CM; Baker F; Casey MJ; Duffy GJ
J Nucl Med; 1991 Dec; 32(12):2281-3. PubMed ID: 1744716
[TBL] [Abstract][Full Text] [Related]
17. Bone and liver images in medullary carcinoma of the thyroid gland: concise communication.
Johnson DG; Coleman RE; McCook TA; Dale JK; Wells SA
J Nucl Med; 1984 Apr; 25(4):419-22. PubMed ID: 6544812
[TBL] [Abstract][Full Text] [Related]
18. A new imaging agent for medullary carcinoma of the thyroid.
Ohta H; Yamamoto K; Endo K; Mori T; Hamanaka D; Shimazu A; Ikekubo K; Makimoto K; Iida Y; Konishi J
J Nucl Med; 1984 Mar; 25(3):323-5. PubMed ID: 6321700
[TBL] [Abstract][Full Text] [Related]
19. [The detection of metastases of ovarian carcinoma by immunoscintigraphy with monoclonal antibodies].
Peking A; Marinov V
Akush Ginekol (Sofiia); 1990; 29(1):57-60. PubMed ID: 2164792
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin and somatostatin analogues in medullary thyroid carcinoma.
O'Byrne KJ; O'Hare N; Sweeney E; Freyne PJ; Cullen MJ
Nucl Med Commun; 1996 Sep; 17(9):810-6. PubMed ID: 8895910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
